{"gene":"NDUFS3","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":2007,"finding":"NDUFS3 is incorporated into Complex I through stepwise assembly: using an inducible NDUFS3-GFP expression system, six distinct NDUFS3-GFP-containing subcomplexes were identified on blue native Western blots, and inhibition of mitochondrial translation caused accumulation of ~100 and ~150 kDa NDUFS3-containing subcomplexes, demonstrating these are true assembly intermediates. Incorporation of at least one mitochondrially-encoded subunit was shown to occur at this step, defining the entry point of mitochondrial DNA-encoded subunits into Complex I assembly.","method":"Inducible NDUFS3-GFP expression in HEK293 cells, blue native Western blot, differential detergent solubilization, heat incubation, mitochondrial translation inhibition","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — direct pulse-chase assembly experiment with tagged protein, multiple orthogonal methods (BN-PAGE, differential solubilization, translation inhibition/release), rigorous controls distinguishing assembly intermediates from degradation products","pmids":["17209039"],"is_preprint":false},{"year":2021,"finding":"NDUFS3 is a non-catalytic core subunit of Complex I whose complete ablation in diverse mammalian cell types still permits a small amount of functional CI to be assembled. Gradual reduction of NDUFS3 causes hierarchical, modular disassembly in which the ND4 module remains stable and bound to TMEM126A, thereby revealing TMEM126A as a CI assembly factor that interacts with the ND4-module intermediate.","method":"NDUFS3 knockout and knockdown in multiple mammalian cell lines, functional CI assays, blue native PAGE, co-immunoprecipitation of TMEM126A with ND4-module","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — complete knockout plus graded knockdown, multiple cell types, functional CI measurement, co-IP identifying TMEM126A binding partner, multiple orthogonal methods in single rigorous study","pmids":["33882309"],"is_preprint":false},{"year":2004,"finding":"Mutations in NDUFS3 (the seventh core subunit of Complex I, encoding an Fe-S protein) cause Complex I deficiency and late-onset Leigh syndrome with optic atrophy, establishing NDUFS3 as an essential structural component of the Complex I catalytic core whose loss abolishes enzyme activity.","method":"DHPLC and sequencing of NDUFS3 in Complex I-deficient patients; biochemical diagnosis of CI deficiency in cultured amniocytes confirmed by mutation identification","journal":"Journal of medical genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — patient mutation identification combined with biochemical CI activity measurements in cultured cells, single study but two orthogonal approaches","pmids":["14729820"],"is_preprint":false},{"year":2013,"finding":"NDUFS3 gene silencing in human embryonic kidney cells causes mitochondrial dysfunction, reduces Complex I activity, and induces a switch to aerobic glycolysis in a manner dependent on NDUFS3 protein levels; sustained free radical imbalance (ROS) is required to maintain the glycolytic metabolic switch in cells with the most severe NDUFS3 suppression.","method":"Stable lentiviral shRNA knockdown of NDUFS3 in HEK293 cells, Seahorse metabolic flux analysis, ROS measurement, Complex I activity assays","journal":"Biology open","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean loss-of-function with multiple metabolic readouts in isogenic cell lines, single laboratory","pmids":["23519235"],"is_preprint":false},{"year":2013,"finding":"The disease-associated double mutant (T145I + R199W) NDUFS3 protein exhibits altered secondary and tertiary structure, altered polarity around tryptophan residues, and a higher tendency toward aggregation compared to wild-type protein, providing a structural basis for how these mutations disrupt Complex I assembly.","method":"Recombinant expression and purification of wild-type and double-mutant NDUFS3 in E. coli, steady-state and time-resolved fluorescence spectroscopy, CD spectroscopy, Thioflavin-T and Congo red dye binding, thermal and Gdn-HCl denaturation","journal":"Biochimie","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with purified protein and multiple biophysical methods, single laboratory","pmids":["24028823"],"is_preprint":false},{"year":2018,"finding":"DJ-1 (PARK7 gene product) physically interacts with NDUFS3 in rat testes; this interaction is weakened by oxidative stress (ornithine treatment), and reduced DJ-1 is accompanied by decreased NDUFS3 expression and reduced Complex I activity, suggesting DJ-1 protects NDUFS3 stability/function.","method":"Co-immunoprecipitation of DJ-1 and NDUFS3 in rat testes, Western blot of NDUFS3 and DJ-1, Complex I activity assay in rat asthenozoospermia model","journal":"Mediators of inflammation","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — co-IP interaction plus functional CI activity assay in animal model, single laboratory but two methods","pmids":["29849492"],"is_preprint":false},{"year":2018,"finding":"Two compound heterozygous missense mutations in NDUFS3 (c.418 C>T/p.R140W and c.595 C>T/p.R199W) decrease both NDUFS3 protein levels and Complex I assembly in patient-derived lymphoblastoid cells, confirming that NDUFS3 is required for proper Complex I assembly.","method":"Next-generation sequencing (MitoExome), Western blot and blue native PAGE of Complex I in patient lymphoblastoid cells vs. controls","journal":"Journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — patient-derived cell biochemistry with BN-PAGE assembly assay and quantitative Western blot, single study","pmids":["30140060"],"is_preprint":false},{"year":2024,"finding":"The splicing factor SRSF1 binds constitutive exon 6 of Ndufs3 pre-mRNA and promotes its inclusion; adipocyte-specific SRSF1 deficiency causes impaired Ndufs3 splicing, reduced functional NDUFS3 protein, defective Complex I assembly and activity, fragmented/degenerated mitochondria, and impaired thermogenesis in brown adipose tissue.","method":"SRSF1 conditional knockout in adipocytes (mice), single-nucleus RNA sequencing, transmission electron microscopy, RIP or CLIP-based binding assay of SRSF1 to Ndufs3 exon 6, Complex I activity assay","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with defined molecular (splicing) and functional (CI activity, mitochondrial morphology, thermogenesis) phenotype, direct binding shown, single laboratory","pmids":["38569495"],"is_preprint":false},{"year":2022,"finding":"NDUFS3 knockout cancer cells showed that BAY 87-2243 and EVP 4593 are selective Complex I inhibitors (their antiproliferative effects are abolished in CI-null cells), while metformin's antiproliferative effects are largely CI-independent. Molecular docking indicates BAY 87-2243 and EVP 4593 bind in the quinone-binding pocket of CI with amino acids conserved across species.","method":"NDUFS3 knockout cancer cell lines (CI-null model), antiproliferative assays, molecular docking into CI quinone-binding pocket","journal":"Open biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean genetic ablation (KO) as mechanistic tool with functional drug-specificity readout plus molecular docking; single laboratory","pmids":["36349591"],"is_preprint":false},{"year":2025,"finding":"NDUFS3 transient silencing in pancreatic cancer cells reduces oxidative phosphorylation and causes mitochondrial morphology alterations, which leads to RAB7 downregulation and impairment of the late endocytic/lysosomal pathway, resulting in reduced invasiveness and tumorigenic potential; RAB7 modulation in turn regulates vimentin levels and mitochondrial protein levels, demonstrating bidirectional mitochondria-lysosome crosstalk downstream of NDUFS3.","method":"RNAi silencing of NDUFS3 in pancreatic cancer cells, Seahorse assay, TEM, confocal microscopy, Western blot, wound healing and FluoroBlok invasion assay, zymography","journal":"Cell communication and signaling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean RNAi loss-of-function with multiple orthogonal readouts (metabolic, morphological, functional), single laboratory","pmids":["40369571"],"is_preprint":false},{"year":2025,"finding":"In melanoma cells, elevated NDUFS3 promotes OXPHOS and the pentose phosphate pathway while attenuating glycolysis; increased ATP production inhibits AMPK, which normally phosphorylates PRPS1 to suppress its activity, so NDUFS3 overexpression leads to enhanced purine nucleotide biosynthesis and melanoma proliferation via a NDUFS3-AMPK-PRPS1 signaling axis.","method":"NDUFS3 overexpression and knockdown in melanoma cells, Seahorse metabolic flux analysis, AMPK phosphorylation assays, PRPS1 activity measurement, proliferation assays","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function with multiple downstream biochemical readouts and pathway placement via AMPK inhibition experiments, single laboratory","pmids":["40404919"],"is_preprint":false},{"year":2024,"finding":"In a PINK1B9 Drosophila model of Parkinson's disease, downregulation of NDUFS3 by RNAi had a protective effect on the transgenic flies, suggesting that reducing NDUFS3-dependent Complex I activity can ameliorate PINK1 loss-of-function phenotypes via reduction of oxidative stress.","method":"NDUFS3 RNAi in MHC-Gal4/UAS PINK1B9 transgenic Drosophila, behavioral and viability phenotyping, ROS/oxidative stress measurements","journal":"Neuroscience letters","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single genetic manipulation in Drosophila model with phenotypic readout but limited mechanistic depth and single laboratory","pmids":["39102941"],"is_preprint":false}],"current_model":"NDUFS3 is a non-catalytic core subunit of the Q/ND4 module of mitochondrial respiratory Complex I that is required for stepwise, modular CI assembly — entering early ~100–150 kDa intermediates before incorporation of mitochondrially encoded subunits — and whose loss causes hierarchical CI disassembly in which the ND4 module remains stable and bound to the assembly factor TMEM126A; correct splicing of NDUFS3 pre-mRNA is controlled by SRSF1, its protein stability is protected by the DJ-1/PARK7 interaction, and beyond its bioenergetic role it couples OXPHOS output to AMPK-PRPS1-mediated purine biosynthesis and, via ROS levels, to metabolic reprogramming between oxidative phosphorylation and glycolysis."},"narrative":{"mechanistic_narrative":"NDUFS3 is a non-catalytic core subunit of mitochondrial respiratory Complex I (CI) that is required for the stepwise, modular assembly of the enzyme [PMID:17209039, PMID:33882309]. During biogenesis, NDUFS3 enters early ~100–150 kDa assembly intermediates that subsequently incorporate mitochondrially encoded subunits, defining the entry point of mtDNA-encoded subunits into CI [PMID:17209039]. Loss of NDUFS3 drives hierarchical, modular CI disassembly in which the ND4 module remains stable and bound to the assembly factor TMEM126A, while complete ablation still permits assembly of a small amount of functional CI [PMID:33882309]. The supply of functional NDUFS3 is regulated upstream by SRSF1, which binds exon 6 of Ndufs3 pre-mRNA to promote its inclusion and ensure proper splicing [PMID:38569495], and the protein is stabilized through physical interaction with DJ-1/PARK7, an interaction weakened by oxidative stress [PMID:29849492]. Beyond its bioenergetic role, NDUFS3-dependent OXPHOS output is coupled to metabolic reprogramming: its loss reduces CI activity and shifts cells toward aerobic glycolysis in a ROS-dependent manner [PMID:23519235], whereas elevated NDUFS3 enhances OXPHOS and purine nucleotide biosynthesis through an AMPK–PRPS1 signaling axis to support proliferation [PMID:40404919]. Pathogenic NDUFS3 mutations decrease protein levels and CI assembly, causing Complex I deficiency and late-onset Leigh syndrome with optic atrophy [PMID:14729820, PMID:30140060].","teleology":[{"year":2004,"claim":"Establishing whether NDUFS3 is merely associated with CI or an essential structural component answered the question of its functional necessity and clinical relevance.","evidence":"Sequencing of NDUFS3 in CI-deficient patients with biochemical confirmation in cultured amniocytes","pmids":["14729820"],"confidence":"Medium","gaps":["Does not resolve at which assembly step NDUFS3 acts","Mechanism linking mutation to loss of activity not defined"]},{"year":2007,"claim":"Defining when and how NDUFS3 enters CI clarified the order of modular assembly and pinpointed the entry of mtDNA-encoded subunits.","evidence":"Inducible NDUFS3-GFP in HEK293 cells with blue native Western blot and mitochondrial translation inhibition","pmids":["17209039"],"confidence":"High","gaps":["Identity of all subcomplex partners not fully resolved","Assembly factors recruiting NDUFS3 not identified at this stage"]},{"year":2013,"claim":"Determining the consequences of NDUFS3 loss for cellular metabolism showed it couples CI output to the choice between OXPHOS and glycolysis via ROS.","evidence":"Stable shRNA knockdown in HEK293 cells with Seahorse flux, ROS measurement, and CI activity assays","pmids":["23519235"],"confidence":"Medium","gaps":["Molecular link between ROS and glycolytic switch not defined","Single cell type"]},{"year":2013,"claim":"Characterizing how disease mutations alter NDUFS3 itself provided a structural basis for assembly failure.","evidence":"Recombinant wild-type and double-mutant (T145I+R199W) NDUFS3 analyzed by fluorescence, CD, and aggregation assays","pmids":["24028823"],"confidence":"Medium","gaps":["In vitro behavior not validated in mitochondria","Aggregation propensity not linked to specific assembly intermediate defect"]},{"year":2018,"claim":"Identifying DJ-1/PARK7 as a physical partner addressed how NDUFS3 stability is protected under oxidative conditions.","evidence":"Co-immunoprecipitation and Western blot with CI activity assay in a rat asthenozoospermia model","pmids":["29849492"],"confidence":"Medium","gaps":["Direct vs. indirect interaction not resolved","Mechanism by which DJ-1 stabilizes NDUFS3 unknown","Single model system"]},{"year":2018,"claim":"Patient-derived compound heterozygous mutations confirmed that NDUFS3 levels directly limit CI assembly, reinforcing its causal role in disease.","evidence":"MitoExome sequencing with BN-PAGE and Western blot in patient lymphoblastoid cells","pmids":["30140060"],"confidence":"Medium","gaps":["Genotype–phenotype correlation across mutations not established","Tissue-specific severity not addressed"]},{"year":2021,"claim":"Graded NDUFS3 depletion resolved the hierarchy of CI disassembly and revealed TMEM126A as an ND4-module assembly factor.","evidence":"Knockout and knockdown in multiple cell lines with functional CI assays, BN-PAGE, and TMEM126A co-IP","pmids":["33882309"],"confidence":"High","gaps":["How residual CI assembles without NDUFS3 unexplained","Structural detail of TMEM126A–ND4 module interaction not defined"]},{"year":2022,"claim":"Using NDUFS3-null cells as a CI-null tool distinguished true CI-targeting drugs from CI-independent agents.","evidence":"NDUFS3 knockout cancer cell lines with antiproliferative assays and molecular docking into the quinone pocket","pmids":["36349591"],"confidence":"Medium","gaps":["Docking predictions not confirmed by structural binding data","NDUFS3's own role in the quinone pocket not addressed"]},{"year":2024,"claim":"Identifying SRSF1-mediated splicing of Ndufs3 exon 6 defined an upstream control point governing functional NDUFS3 production and tissue energetics.","evidence":"Adipocyte-specific SRSF1 knockout mice with snRNA-seq, binding assays, TEM, and CI activity measurement","pmids":["38569495"],"confidence":"Medium","gaps":["Whether splicing regulation operates in other tissues unknown","Other SRSF1 targets contributing to phenotype not excluded"]},{"year":2024,"claim":"Testing NDUFS3 reduction in a PINK1 Parkinson's model probed whether lowering CI activity can be protective via reduced oxidative stress.","evidence":"NDUFS3 RNAi in PINK1B9 Drosophila with behavioral, viability, and ROS phenotyping","pmids":["39102941"],"confidence":"Low","gaps":["Single genetic manipulation with limited mechanistic depth","Not confirmed in mammalian neurons","Direct ROS-protection causality not established"]},{"year":2025,"claim":"Linking NDUFS3 loss to RAB7 and the endolysosomal pathway revealed mitochondria–lysosome crosstalk influencing tumor invasiveness.","evidence":"RNAi silencing in pancreatic cancer cells with Seahorse, TEM, invasion assays, and Western blot","pmids":["40369571"],"confidence":"Medium","gaps":["Signal connecting mitochondrial dysfunction to RAB7 downregulation undefined","Single cancer type"]},{"year":2025,"claim":"Defining the NDUFS3–AMPK–PRPS1 axis explained how NDUFS3-driven OXPHOS output is converted into purine biosynthesis and proliferative advantage.","evidence":"NDUFS3 overexpression and knockdown in melanoma cells with Seahorse, AMPK phosphorylation, and PRPS1 activity assays","pmids":["40404919"],"confidence":"Medium","gaps":["Generalizability beyond melanoma not established","Direct vs. ATP-mediated regulation of AMPK by NDUFS3 not dissected"]},{"year":null,"claim":"How NDUFS3 abundance and assembly state are integrated across regulatory inputs (SRSF1 splicing, DJ-1 stabilization, ROS) to control CI biogenesis and downstream metabolic signaling in a tissue-specific manner remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No unified model connecting upstream regulators to assembly intermediates","Structural mechanism of NDUFS3 within early intermediates undefined","Tissue-specific phenotypic determinants unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,1,2]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,1,7]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[3,10]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[0,1]}],"complexes":["Mitochondrial respiratory Complex I","Complex I ND4 module"],"partners":["TMEM126A","PARK7","SRSF1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O75489","full_name":"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial","aliases":["Complex I-30kD","CI-30kD","NADH-ubiquinone oxidoreductase 30 kDa subunit"],"length_aa":264,"mass_kda":30.2,"function":"Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:14729820, PubMed:30140060). Essential for the catalytic activity and assembly of complex I (PubMed:14729820, PubMed:24028823, PubMed:30140060)","subcellular_location":"Mitochondrion inner membrane","url":"https://www.uniprot.org/uniprotkb/O75489/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NDUFS3","classification":"Not Classified","n_dependent_lines":354,"n_total_lines":1208,"dependency_fraction":0.29304635761589404},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NDUFS3","total_profiled":1310},"omim":[{"mim_id":"620135","title":"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 39; MC1DN39","url":"https://www.omim.org/entry/620135"},{"mim_id":"620018","title":"PROTEIN DISULFIDE ISOMERASE, FAMILY A, MEMBER 4; PDIA4","url":"https://www.omim.org/entry/620018"},{"mim_id":"618230","title":"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8","url":"https://www.omim.org/entry/618230"},{"mim_id":"612360","title":"NADH DEHYDROGENASE (UBIQUINONE) COMPLEX I, ASSEMBLY FACTOR 5; NDUFAF5","url":"https://www.omim.org/entry/612360"},{"mim_id":"609435","title":"NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT A13; NDUFA13","url":"https://www.omim.org/entry/609435"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Mitochondria","reliability":"Supported"},{"location":"Nuclear bodies","reliability":"Additional"},{"location":"Principal piece","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"skeletal muscle","ntpm":318.8}],"url":"https://www.proteinatlas.org/search/NDUFS3"},"hgnc":{"alias_symbol":["CI-30"],"prev_symbol":[]},"alphafold":{"accession":"O75489","domains":[{"cath_id":"3.30.460.80","chopping":"53-185","consensus_level":"high","plddt":94.8906,"start":53,"end":185}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O75489","model_url":"https://alphafold.ebi.ac.uk/files/AF-O75489-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O75489-F1-predicted_aligned_error_v6.png","plddt_mean":82.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NDUFS3","jax_strain_url":"https://www.jax.org/strain/search?query=NDUFS3"},"sequence":{"accession":"O75489","fasta_url":"https://rest.uniprot.org/uniprotkb/O75489.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O75489/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O75489"}},"corpus_meta":[{"pmid":"14729820","id":"PMC_14729820","title":"Mutant NDUFS3 subunit of mitochondrial complex I causes Leigh syndrome.","date":"2004","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14729820","citation_count":148,"is_preprint":false},{"pmid":"17209039","id":"PMC_17209039","title":"Identification of mitochondrial complex I assembly intermediates by tracing tagged NDUFS3 demonstrates the entry point of mitochondrial subunits.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17209039","citation_count":125,"is_preprint":false},{"pmid":"23519235","id":"PMC_23519235","title":"Mitochondrial NDUFS3 regulates the ROS-mediated onset of metabolic switch in transformed cells.","date":"2013","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/23519235","citation_count":39,"is_preprint":false},{"pmid":"21867691","id":"PMC_21867691","title":"Biomarker signatures of mitochondrial NDUFS3 in invasive breast carcinoma.","date":"2011","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/21867691","citation_count":30,"is_preprint":false},{"pmid":"33882309","id":"PMC_33882309","title":"NDUFS3 depletion permits complex I maturation and reveals TMEM126A/OPA7 as an assembly factor binding the ND4-module intermediate.","date":"2021","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/33882309","citation_count":24,"is_preprint":false},{"pmid":"31645842","id":"PMC_31645842","title":"Metformin restores the mitochondrial membrane potentials in association with a reduction in TIMM23 and NDUFS3 in MPP+-induced neurotoxicity in SH-SY5Y cells.","date":"2019","source":"EXCLI journal","url":"https://pubmed.ncbi.nlm.nih.gov/31645842","citation_count":22,"is_preprint":false},{"pmid":"22387129","id":"PMC_22387129","title":"Mitochondrial proteome analysis reveals depression of the Ndufs3 subunit and activity of complex I in diabetic rat brain.","date":"2012","source":"Journal of proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/22387129","citation_count":22,"is_preprint":false},{"pmid":"30140060","id":"PMC_30140060","title":"A Novel NDUFS3 mutation in a Chinese patient with severe Leigh syndrome.","date":"2018","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30140060","citation_count":20,"is_preprint":false},{"pmid":"24028823","id":"PMC_24028823","title":"Human mitochondrial NDUFS3 protein bearing Leigh syndrome mutation is more prone to aggregation than its wild-type.","date":"2013","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/24028823","citation_count":17,"is_preprint":false},{"pmid":"39426231","id":"PMC_39426231","title":"NDUFS3 alleviates oxidative stress and ferroptosis in sepsis induced acute kidney injury through AMPK pathway.","date":"2024","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39426231","citation_count":16,"is_preprint":false},{"pmid":"38569495","id":"PMC_38569495","title":"SRSF1 Is Required for Mitochondrial Homeostasis and Thermogenic Function in Brown Adipocytes Through its Control of Ndufs3 Splicing.","date":"2024","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/38569495","citation_count":14,"is_preprint":false},{"pmid":"29849492","id":"PMC_29849492","title":"Downregulation of DJ-1 Fails to Protect Mitochondrial Complex I Subunit NDUFS3 in the Testes and Contributes to the Asthenozoospermia.","date":"2018","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/29849492","citation_count":14,"is_preprint":false},{"pmid":"36349549","id":"PMC_36349549","title":"NDUFS3 knockout cancer cells and molecular docking reveal specificity and mode of action of anti-cancer respiratory complex I inhibitors.","date":"2022","source":"Open biology","url":"https://pubmed.ncbi.nlm.nih.gov/36349549","citation_count":13,"is_preprint":false},{"pmid":"23446378","id":"PMC_23446378","title":"Reduced expression of NDUFS3 and its clinical significance in serous ovarian cancer.","date":"2013","source":"International journal of gynecological cancer : official journal of the International Gynecological Cancer Society","url":"https://pubmed.ncbi.nlm.nih.gov/23446378","citation_count":11,"is_preprint":false},{"pmid":"37642954","id":"PMC_37642954","title":"NDUFB11 and NDUFS3 play a role in atherosclerosis and chronic stress.","date":"2023","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/37642954","citation_count":9,"is_preprint":false},{"pmid":"40404919","id":"PMC_40404919","title":"NDUFS3 promotes proliferation via glucose metabolism reprogramming inducing AMPK phosphorylating PRPS1 to increase the purine nucleotide synthesis in melanoma.","date":"2025","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/40404919","citation_count":6,"is_preprint":false},{"pmid":"36531773","id":"PMC_36531773","title":"Mitochondrial Ultrastructural Defects in NDUFS3-Related Disorder.","date":"2021","source":"Journal of pediatric neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/36531773","citation_count":5,"is_preprint":false},{"pmid":"37986300","id":"PMC_37986300","title":"NDUFB11 and NDUFS3 regulate arterial atherosclerosis and venous thrombosis: Potential markers of atherosclerosis and venous thrombosis.","date":"2023","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37986300","citation_count":4,"is_preprint":false},{"pmid":"39532991","id":"PMC_39532991","title":"Molecular mechanisms of MAZ targeting up-regulation of NDUFS3 expression to promote malignant progression in melanoma.","date":"2024","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/39532991","citation_count":4,"is_preprint":false},{"pmid":"30266949","id":"PMC_30266949","title":"Correction: A novel NDUFS3 mutation in a Chinese patient with severe Leigh syndrome.","date":"2018","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30266949","citation_count":4,"is_preprint":false},{"pmid":"40369571","id":"PMC_40369571","title":"Induced mitochondrial deficit by NDUFS3 transient silencing reduces RAB7 expression and causes lysosomal dysfunction in pancreatic cancer cells.","date":"2025","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/40369571","citation_count":3,"is_preprint":false},{"pmid":"39102941","id":"PMC_39102941","title":"Mitochondrial dysfunction and NDUFS3: Insights from a PINK1B9 Drosophila model in Parkinson's disease pathogenesis.","date":"2024","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/39102941","citation_count":3,"is_preprint":false},{"pmid":"39006971","id":"PMC_39006971","title":"Moringa oleifera leaf extract suppresses TIMM23 and NDUFS3 expression and alleviates oxidative stress induced by Aβ1-42 in neuronal cells via activation of Akt.","date":"2024","source":"Research in pharmaceutical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39006971","citation_count":2,"is_preprint":false},{"pmid":"40435704","id":"PMC_40435704","title":"Screening ligands interacting with NDUFS3 from Oroxylum indicum extract using bioaffinity ultrafiltration combined with in vitro protein purification.","date":"2025","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/40435704","citation_count":0,"is_preprint":false},{"pmid":"42232357","id":"PMC_42232357","title":"An Atypical Neurosensory-Predominant Presentation Associated with a Homozygous NDUFS3 Variant: A Diagnostic Challenge Involving Retinal and Hearing Phenotypes.","date":"2026","source":"Molecular syndromology","url":"https://pubmed.ncbi.nlm.nih.gov/42232357","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.13.25337858","title":"The tissue-specific effects of glucose-lowering drug targets on aging mediated through DNA methylation: a multi-omics genetic study","date":"2025-10-14","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.13.25337858","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.09.15.676326","title":"Long non-coding RNA Cerox1 targets components of the mitochondrial electron transport chain to regulate the memory impairment caused by sleep deprivation","date":"2025-09-17","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.15.676326","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.08.12.669930","title":"Altered molecular signaling pathways in the hippocampus of rhesus monkeys following chronic alcohol use","date":"2025-08-15","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.12.669930","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.06.19.660636","title":"The genetic origin of fetal growth restriction and mitochondrial complex I dysregulation","date":"2025-06-21","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.19.660636","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.07.29.24311063","title":"Loss of heterozygosity in gastric cancers in a set of Mexican patients","date":"2024-07-29","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.29.24311063","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":16947,"output_tokens":3315,"usd":0.050283,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10953,"output_tokens":3556,"usd":0.071832,"stage2_stop_reason":"end_turn"},"total_usd":0.122115,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"NDUFS3 is incorporated into Complex I through stepwise assembly: using an inducible NDUFS3-GFP expression system, six distinct NDUFS3-GFP-containing subcomplexes were identified on blue native Western blots, and inhibition of mitochondrial translation caused accumulation of ~100 and ~150 kDa NDUFS3-containing subcomplexes, demonstrating these are true assembly intermediates. Incorporation of at least one mitochondrially-encoded subunit was shown to occur at this step, defining the entry point of mitochondrial DNA-encoded subunits into Complex I assembly.\",\n      \"method\": \"Inducible NDUFS3-GFP expression in HEK293 cells, blue native Western blot, differential detergent solubilization, heat incubation, mitochondrial translation inhibition\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — direct pulse-chase assembly experiment with tagged protein, multiple orthogonal methods (BN-PAGE, differential solubilization, translation inhibition/release), rigorous controls distinguishing assembly intermediates from degradation products\",\n      \"pmids\": [\"17209039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NDUFS3 is a non-catalytic core subunit of Complex I whose complete ablation in diverse mammalian cell types still permits a small amount of functional CI to be assembled. Gradual reduction of NDUFS3 causes hierarchical, modular disassembly in which the ND4 module remains stable and bound to TMEM126A, thereby revealing TMEM126A as a CI assembly factor that interacts with the ND4-module intermediate.\",\n      \"method\": \"NDUFS3 knockout and knockdown in multiple mammalian cell lines, functional CI assays, blue native PAGE, co-immunoprecipitation of TMEM126A with ND4-module\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — complete knockout plus graded knockdown, multiple cell types, functional CI measurement, co-IP identifying TMEM126A binding partner, multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"33882309\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Mutations in NDUFS3 (the seventh core subunit of Complex I, encoding an Fe-S protein) cause Complex I deficiency and late-onset Leigh syndrome with optic atrophy, establishing NDUFS3 as an essential structural component of the Complex I catalytic core whose loss abolishes enzyme activity.\",\n      \"method\": \"DHPLC and sequencing of NDUFS3 in Complex I-deficient patients; biochemical diagnosis of CI deficiency in cultured amniocytes confirmed by mutation identification\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — patient mutation identification combined with biochemical CI activity measurements in cultured cells, single study but two orthogonal approaches\",\n      \"pmids\": [\"14729820\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NDUFS3 gene silencing in human embryonic kidney cells causes mitochondrial dysfunction, reduces Complex I activity, and induces a switch to aerobic glycolysis in a manner dependent on NDUFS3 protein levels; sustained free radical imbalance (ROS) is required to maintain the glycolytic metabolic switch in cells with the most severe NDUFS3 suppression.\",\n      \"method\": \"Stable lentiviral shRNA knockdown of NDUFS3 in HEK293 cells, Seahorse metabolic flux analysis, ROS measurement, Complex I activity assays\",\n      \"journal\": \"Biology open\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean loss-of-function with multiple metabolic readouts in isogenic cell lines, single laboratory\",\n      \"pmids\": [\"23519235\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The disease-associated double mutant (T145I + R199W) NDUFS3 protein exhibits altered secondary and tertiary structure, altered polarity around tryptophan residues, and a higher tendency toward aggregation compared to wild-type protein, providing a structural basis for how these mutations disrupt Complex I assembly.\",\n      \"method\": \"Recombinant expression and purification of wild-type and double-mutant NDUFS3 in E. coli, steady-state and time-resolved fluorescence spectroscopy, CD spectroscopy, Thioflavin-T and Congo red dye binding, thermal and Gdn-HCl denaturation\",\n      \"journal\": \"Biochimie\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with purified protein and multiple biophysical methods, single laboratory\",\n      \"pmids\": [\"24028823\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"DJ-1 (PARK7 gene product) physically interacts with NDUFS3 in rat testes; this interaction is weakened by oxidative stress (ornithine treatment), and reduced DJ-1 is accompanied by decreased NDUFS3 expression and reduced Complex I activity, suggesting DJ-1 protects NDUFS3 stability/function.\",\n      \"method\": \"Co-immunoprecipitation of DJ-1 and NDUFS3 in rat testes, Western blot of NDUFS3 and DJ-1, Complex I activity assay in rat asthenozoospermia model\",\n      \"journal\": \"Mediators of inflammation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — co-IP interaction plus functional CI activity assay in animal model, single laboratory but two methods\",\n      \"pmids\": [\"29849492\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Two compound heterozygous missense mutations in NDUFS3 (c.418 C>T/p.R140W and c.595 C>T/p.R199W) decrease both NDUFS3 protein levels and Complex I assembly in patient-derived lymphoblastoid cells, confirming that NDUFS3 is required for proper Complex I assembly.\",\n      \"method\": \"Next-generation sequencing (MitoExome), Western blot and blue native PAGE of Complex I in patient lymphoblastoid cells vs. controls\",\n      \"journal\": \"Journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — patient-derived cell biochemistry with BN-PAGE assembly assay and quantitative Western blot, single study\",\n      \"pmids\": [\"30140060\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The splicing factor SRSF1 binds constitutive exon 6 of Ndufs3 pre-mRNA and promotes its inclusion; adipocyte-specific SRSF1 deficiency causes impaired Ndufs3 splicing, reduced functional NDUFS3 protein, defective Complex I assembly and activity, fragmented/degenerated mitochondria, and impaired thermogenesis in brown adipose tissue.\",\n      \"method\": \"SRSF1 conditional knockout in adipocytes (mice), single-nucleus RNA sequencing, transmission electron microscopy, RIP or CLIP-based binding assay of SRSF1 to Ndufs3 exon 6, Complex I activity assay\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with defined molecular (splicing) and functional (CI activity, mitochondrial morphology, thermogenesis) phenotype, direct binding shown, single laboratory\",\n      \"pmids\": [\"38569495\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"NDUFS3 knockout cancer cells showed that BAY 87-2243 and EVP 4593 are selective Complex I inhibitors (their antiproliferative effects are abolished in CI-null cells), while metformin's antiproliferative effects are largely CI-independent. Molecular docking indicates BAY 87-2243 and EVP 4593 bind in the quinone-binding pocket of CI with amino acids conserved across species.\",\n      \"method\": \"NDUFS3 knockout cancer cell lines (CI-null model), antiproliferative assays, molecular docking into CI quinone-binding pocket\",\n      \"journal\": \"Open biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic ablation (KO) as mechanistic tool with functional drug-specificity readout plus molecular docking; single laboratory\",\n      \"pmids\": [\"36349591\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"NDUFS3 transient silencing in pancreatic cancer cells reduces oxidative phosphorylation and causes mitochondrial morphology alterations, which leads to RAB7 downregulation and impairment of the late endocytic/lysosomal pathway, resulting in reduced invasiveness and tumorigenic potential; RAB7 modulation in turn regulates vimentin levels and mitochondrial protein levels, demonstrating bidirectional mitochondria-lysosome crosstalk downstream of NDUFS3.\",\n      \"method\": \"RNAi silencing of NDUFS3 in pancreatic cancer cells, Seahorse assay, TEM, confocal microscopy, Western blot, wound healing and FluoroBlok invasion assay, zymography\",\n      \"journal\": \"Cell communication and signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean RNAi loss-of-function with multiple orthogonal readouts (metabolic, morphological, functional), single laboratory\",\n      \"pmids\": [\"40369571\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In melanoma cells, elevated NDUFS3 promotes OXPHOS and the pentose phosphate pathway while attenuating glycolysis; increased ATP production inhibits AMPK, which normally phosphorylates PRPS1 to suppress its activity, so NDUFS3 overexpression leads to enhanced purine nucleotide biosynthesis and melanoma proliferation via a NDUFS3-AMPK-PRPS1 signaling axis.\",\n      \"method\": \"NDUFS3 overexpression and knockdown in melanoma cells, Seahorse metabolic flux analysis, AMPK phosphorylation assays, PRPS1 activity measurement, proliferation assays\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function with multiple downstream biochemical readouts and pathway placement via AMPK inhibition experiments, single laboratory\",\n      \"pmids\": [\"40404919\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In a PINK1B9 Drosophila model of Parkinson's disease, downregulation of NDUFS3 by RNAi had a protective effect on the transgenic flies, suggesting that reducing NDUFS3-dependent Complex I activity can ameliorate PINK1 loss-of-function phenotypes via reduction of oxidative stress.\",\n      \"method\": \"NDUFS3 RNAi in MHC-Gal4/UAS PINK1B9 transgenic Drosophila, behavioral and viability phenotyping, ROS/oxidative stress measurements\",\n      \"journal\": \"Neuroscience letters\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single genetic manipulation in Drosophila model with phenotypic readout but limited mechanistic depth and single laboratory\",\n      \"pmids\": [\"39102941\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NDUFS3 is a non-catalytic core subunit of the Q/ND4 module of mitochondrial respiratory Complex I that is required for stepwise, modular CI assembly — entering early ~100–150 kDa intermediates before incorporation of mitochondrially encoded subunits — and whose loss causes hierarchical CI disassembly in which the ND4 module remains stable and bound to the assembly factor TMEM126A; correct splicing of NDUFS3 pre-mRNA is controlled by SRSF1, its protein stability is protected by the DJ-1/PARK7 interaction, and beyond its bioenergetic role it couples OXPHOS output to AMPK-PRPS1-mediated purine biosynthesis and, via ROS levels, to metabolic reprogramming between oxidative phosphorylation and glycolysis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"NDUFS3 is a non-catalytic core subunit of mitochondrial respiratory Complex I (CI) that is required for the stepwise, modular assembly of the enzyme [#0, #1]. During biogenesis, NDUFS3 enters early ~100–150 kDa assembly intermediates that subsequently incorporate mitochondrially encoded subunits, defining the entry point of mtDNA-encoded subunits into CI [#0]. Loss of NDUFS3 drives hierarchical, modular CI disassembly in which the ND4 module remains stable and bound to the assembly factor TMEM126A, while complete ablation still permits assembly of a small amount of functional CI [#1]. The supply of functional NDUFS3 is regulated upstream by SRSF1, which binds exon 6 of Ndufs3 pre-mRNA to promote its inclusion and ensure proper splicing [#7], and the protein is stabilized through physical interaction with DJ-1/PARK7, an interaction weakened by oxidative stress [#5]. Beyond its bioenergetic role, NDUFS3-dependent OXPHOS output is coupled to metabolic reprogramming: its loss reduces CI activity and shifts cells toward aerobic glycolysis in a ROS-dependent manner [#3], whereas elevated NDUFS3 enhances OXPHOS and purine nucleotide biosynthesis through an AMPK–PRPS1 signaling axis to support proliferation [#10]. Pathogenic NDUFS3 mutations decrease protein levels and CI assembly, causing Complex I deficiency and late-onset Leigh syndrome with optic atrophy [#2, #6].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Establishing whether NDUFS3 is merely associated with CI or an essential structural component answered the question of its functional necessity and clinical relevance.\",\n      \"evidence\": \"Sequencing of NDUFS3 in CI-deficient patients with biochemical confirmation in cultured amniocytes\",\n      \"pmids\": [\"14729820\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not resolve at which assembly step NDUFS3 acts\", \"Mechanism linking mutation to loss of activity not defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defining when and how NDUFS3 enters CI clarified the order of modular assembly and pinpointed the entry of mtDNA-encoded subunits.\",\n      \"evidence\": \"Inducible NDUFS3-GFP in HEK293 cells with blue native Western blot and mitochondrial translation inhibition\",\n      \"pmids\": [\"17209039\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of all subcomplex partners not fully resolved\", \"Assembly factors recruiting NDUFS3 not identified at this stage\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Determining the consequences of NDUFS3 loss for cellular metabolism showed it couples CI output to the choice between OXPHOS and glycolysis via ROS.\",\n      \"evidence\": \"Stable shRNA knockdown in HEK293 cells with Seahorse flux, ROS measurement, and CI activity assays\",\n      \"pmids\": [\"23519235\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular link between ROS and glycolytic switch not defined\", \"Single cell type\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Characterizing how disease mutations alter NDUFS3 itself provided a structural basis for assembly failure.\",\n      \"evidence\": \"Recombinant wild-type and double-mutant (T145I+R199W) NDUFS3 analyzed by fluorescence, CD, and aggregation assays\",\n      \"pmids\": [\"24028823\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vitro behavior not validated in mitochondria\", \"Aggregation propensity not linked to specific assembly intermediate defect\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identifying DJ-1/PARK7 as a physical partner addressed how NDUFS3 stability is protected under oxidative conditions.\",\n      \"evidence\": \"Co-immunoprecipitation and Western blot with CI activity assay in a rat asthenozoospermia model\",\n      \"pmids\": [\"29849492\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs. indirect interaction not resolved\", \"Mechanism by which DJ-1 stabilizes NDUFS3 unknown\", \"Single model system\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Patient-derived compound heterozygous mutations confirmed that NDUFS3 levels directly limit CI assembly, reinforcing its causal role in disease.\",\n      \"evidence\": \"MitoExome sequencing with BN-PAGE and Western blot in patient lymphoblastoid cells\",\n      \"pmids\": [\"30140060\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Genotype–phenotype correlation across mutations not established\", \"Tissue-specific severity not addressed\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Graded NDUFS3 depletion resolved the hierarchy of CI disassembly and revealed TMEM126A as an ND4-module assembly factor.\",\n      \"evidence\": \"Knockout and knockdown in multiple cell lines with functional CI assays, BN-PAGE, and TMEM126A co-IP\",\n      \"pmids\": [\"33882309\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How residual CI assembles without NDUFS3 unexplained\", \"Structural detail of TMEM126A–ND4 module interaction not defined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Using NDUFS3-null cells as a CI-null tool distinguished true CI-targeting drugs from CI-independent agents.\",\n      \"evidence\": \"NDUFS3 knockout cancer cell lines with antiproliferative assays and molecular docking into the quinone pocket\",\n      \"pmids\": [\"36349591\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Docking predictions not confirmed by structural binding data\", \"NDUFS3's own role in the quinone pocket not addressed\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identifying SRSF1-mediated splicing of Ndufs3 exon 6 defined an upstream control point governing functional NDUFS3 production and tissue energetics.\",\n      \"evidence\": \"Adipocyte-specific SRSF1 knockout mice with snRNA-seq, binding assays, TEM, and CI activity measurement\",\n      \"pmids\": [\"38569495\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether splicing regulation operates in other tissues unknown\", \"Other SRSF1 targets contributing to phenotype not excluded\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Testing NDUFS3 reduction in a PINK1 Parkinson's model probed whether lowering CI activity can be protective via reduced oxidative stress.\",\n      \"evidence\": \"NDUFS3 RNAi in PINK1B9 Drosophila with behavioral, viability, and ROS phenotyping\",\n      \"pmids\": [\"39102941\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single genetic manipulation with limited mechanistic depth\", \"Not confirmed in mammalian neurons\", \"Direct ROS-protection causality not established\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Linking NDUFS3 loss to RAB7 and the endolysosomal pathway revealed mitochondria–lysosome crosstalk influencing tumor invasiveness.\",\n      \"evidence\": \"RNAi silencing in pancreatic cancer cells with Seahorse, TEM, invasion assays, and Western blot\",\n      \"pmids\": [\"40369571\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Signal connecting mitochondrial dysfunction to RAB7 downregulation undefined\", \"Single cancer type\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Defining the NDUFS3–AMPK–PRPS1 axis explained how NDUFS3-driven OXPHOS output is converted into purine biosynthesis and proliferative advantage.\",\n      \"evidence\": \"NDUFS3 overexpression and knockdown in melanoma cells with Seahorse, AMPK phosphorylation, and PRPS1 activity assays\",\n      \"pmids\": [\"40404919\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Generalizability beyond melanoma not established\", \"Direct vs. ATP-mediated regulation of AMPK by NDUFS3 not dissected\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How NDUFS3 abundance and assembly state are integrated across regulatory inputs (SRSF1 splicing, DJ-1 stabilization, ROS) to control CI biogenesis and downstream metabolic signaling in a tissue-specific manner remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No unified model connecting upstream regulators to assembly intermediates\", \"Structural mechanism of NDUFS3 within early intermediates undefined\", \"Tissue-specific phenotypic determinants unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 1, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 1, 7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [3, 10]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"complexes\": [\"Mitochondrial respiratory Complex I\", \"Complex I ND4 module\"],\n    \"partners\": [\"TMEM126A\", \"PARK7\", \"SRSF1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}